Hubrecht Organoid Technology Revenue and Competitors

Utrecht, Netherlands

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Hubrecht Organoid Technology's estimated annual revenue is currently $20.3M per year.(i)
  • Hubrecht Organoid Technology's estimated revenue per employee is $155,000

Employee Data

  • Hubrecht Organoid Technology has 131 Employees.(i)
  • Hubrecht Organoid Technology grew their employee count by 13% last year.

Hubrecht Organoid Technology's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13760M19518-2%$654M$31.7B
Add Company

What Is Hubrecht Organoid Technology?

Hubrecht Organoid Technology (The HUB) is a not-for-profit organization founded by the Hubrecht Institute, KNAW and University Medical Center Utrecht, The Netherlands. The HUB builds a comprehensive Living Biobank of well-characterized organoids and develops assays for drug screening and validation: The Organoid Technology. The HUB offers licenses to its patented Organoid Technology for in-house drug-screening and access to organoids in the Living Biobank for in-house preclinical drug discovery and validation. In addition, the HUB provides drug screening services to third parties. The platform provides an advanced translational medicine approach to validate candidate product leads, and guide the design of clinical trials based on patient stratification.

keywords:N/A

N/A

Total Funding

131

Number of Employees

$20.3M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.8M13240%N/A
#2
$35.9M1336%N/A
#3
$35.9M13323%N/A
#4
$14.2M139-5%N/A
#5
N/A1397%N/A